Lee C S, Guo P
Department of Veterinary Pathobiology, Purdue Cancer Center, Purdue University, West Lafayette, Indiana 47907.
Protein Expr Purif. 1993 Apr;4(2):114-9. doi: 10.1006/prep.1993.1017.
Vaccinia virus (vv) mRNA capping enzyme is composed of a large and a small subunit encoded by genes D1 and D12, respectively. A 38-kDa interfering polypeptide is copurified with the vaccinia virus capping enzyme overproduced in Escherichia coli, but the origin of this polypeptide is unknown (P. Guo and B. Moss, 1990, Proc. Natl. Acad. Sci. USA 87, 4023-4027). This polypeptide competes with the large subunit in binding to the small subunit during the assembly of the heterodimeric enzyme in the cell, resulting in a reduced yield of the active enzyme. Results from the studies of ribosome-binding site replacement, frame shifting, DNA deletion, and in vitro mutagenesis showed that the interfering polypeptide originated from a new translation initiation site within the D1 gene. Transfection of a plasmid containing an internal eukaryotic ribosome binding site into monkey kidney cells infected with vv producing T7 RNA polymerase resulted in the expression of the large subunit up to 30% of total cellular radiolabeled protein; however, the 38-kDa polypeptide was not detected. This finding suggests that the initiation site was recognized only by E. coli, not by eukaryotic cells. The Shine-Dalgarno sequence is not found in the corresponding region preceding the putative start codon, indicating that an unusual mechanism for ribosome binding exists. Mutagenesis of the putative initiation codon of the interfering polypeptide from ATG (Met), coding for residue 498 of the large subunit, to ATA (Ile) eliminated the expression of the interfering polypeptide. A stable and active mutant enzyme was expressed in E. coli HMS174(DE3) cell without the presence of the interfering polypeptide.
痘苗病毒(vv)mRNA 加帽酶由分别由基因 D1 和 D12 编码的一个大亚基和一个小亚基组成。一种 38 kDa 的干扰多肽与在大肠杆菌中过量产生的痘苗病毒加帽酶共纯化,但该多肽的来源尚不清楚(P. Guo 和 B. Moss,1990 年,美国国家科学院院刊 87,4023 - 4027)。在细胞内异二聚体酶组装过程中,该多肽与大亚基竞争结合小亚基,导致活性酶产量降低。核糖体结合位点替换、移码、DNA 缺失和体外诱变研究结果表明,干扰多肽起源于 D1 基因内一个新的翻译起始位点。将含有内部真核核糖体结合位点的质粒转染到感染产生 T7 RNA 聚合酶的 vv 的猴肾细胞中,导致大亚基表达量高达细胞总放射性标记蛋白的 30%;然而,未检测到 38 kDa 的多肽。这一发现表明该起始位点仅被大肠杆菌识别,而不被真核细胞识别。在假定起始密码子之前的相应区域未发现 Shine - Dalgarno 序列,表明存在一种不寻常的核糖体结合机制。将干扰多肽的假定起始密码子从编码大亚基第 498 位残基的 ATG(甲硫氨酸)突变为 ATA(异亮氨酸),消除了干扰多肽的表达。在没有干扰多肽存在的情况下,一种稳定且有活性的突变酶在大肠杆菌 HMS174(DE3)细胞中表达。